Phase 2
Who we are
CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
Nivolumab+Ipilimumab+RT in MSS mCRC
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
